(Q44148330)

English

Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4-methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats

scientific article published in August 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

0 references

Influences of the corticotropic axis and sympathetic activity on neurochemical consequences of 3,4-methylenedioxymethamphetamine (MDMA) administration in Fischer 344 rats (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Francesca Fernandez

object named as

Francesca Fernandez

1

0 references

Francis Chaouloff

object named as

Francis Chaouloff

4

0 references

author name string

Sylvie Aguerre

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Pierre Mormède

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 August 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

European Journal of Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

607-618

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Differential neuroendocrine responses to the 5-HT agonist m-chlorophenylpiperazine in Fawn-Hooded rats relative to Wistar and Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Stress Hormones: Their Interaction and Regulation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hor

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Effects of chlorisondamine and restraint on cortical [3H]ketanserin binding, 5-HT2A receptor-mediated head shakes, and behaviours in models of anxiety.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Chronic central nicotinic blockade after a single administration of the bisquaternary ganglion-blocking drug chlorisondamine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

The pharmacology of the nicotinic antagonist, chlorisondamine, investigated in rat brain and autonomic ganglion

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Neurotoxic effect of MDMA on brain serotonin neurons: evidence from neurochemical and radioligand binding studies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Stress response, adrenal steroid receptor levels and corticosteroid-binding globulin levels--a comparison between Sprague-Dawley, Fischer 344 and Lewis rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Effect of ascorbate and cysteine on the 3,4-methylenedioxymethamphetamine-induced depletion of brain serotonin.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Stress-induced alterations in plasma catecholamines and behavior of rats: Effects of chlorisondamine and bretylium

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Neurotoxicity of MDMA and related compounds: anatomic studies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Cardiovascular and sympathetic responses and reflex changes elicited by MDMA.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Quantitative aspects of drug and toxicant-induced astrogliosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Serotonin reuptake inhibition by citalopram in rat strains differing for their emotionality.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Chronic 3,4-methylenedioxymethamphetamine administration decreases glucocorticoid and mineralocorticoid receptor, but increases 5-hydroxytryptamine1C receptor gene expression in the rat hippocampus

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Acute Toxicity of 3,4-Methylenedioxymethamphetamine (MDMA) in Sprague–Dawley and Dark Agouti Rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1460-9568.2002.02110.X

21 January 2018

Identifiers

10.1046/J.1460-9568.2002.02110.X

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44148330&oldid=2107146544"